MANF: A new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons

Journal of Molecular Neuroscience

Volumn 20, Issue 2, 2003, Pages 173-187

  Petrova, Penka S ^a   Raibekas, Andrei ^a   Pevsner, Jonathan ^b   Vigo, Noel ^a   Anafi, Mordechai ^a   Moore, Mary K ^a   Peaire, Amy E ^a   Shridhar, Viji ^c   Smith, David I ^c   Kelly, John ^d   Durocher, Yves ^d   Commissiong, John W ^a  

^a Prescient NeuroPharma Inc   (Canada)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MAYO CLINIC   (United States)

^d NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Cell line; Neuroprotection; Novel protein; Phenotype specificity; Secreted protein; Type 1 astrocyte

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; COMPLEMENTARY DNA; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MESENCEPHALIC ASTROCYTE DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIC FACTOR; UNCLASSIFIED DRUG;

ALPHA HELIX; ANIMAL CELL; ARTICLE; ASTROCYTE; CAENORHABDITIS ELEGANS; CHROMOSOME 3; CONCENTRATION RESPONSE; DOPAMINERGIC NERVE CELL; EXON; HUMAN; MESENCEPHALON; MOLECULAR CLONING; MONKEY; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PROTEIN LOCALIZATION; RAT; SEROTONINERGIC NERVE CELL; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; ASTROCYTES; BASE SEQUENCE; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL LINE, TRANSFORMED; DNA, COMPLEMENTARY; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; MESENCEPHALON; MOLECULAR SEQUENCE DATA; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEURONS; NEUROPROTECTIVE AGENTS; PARKINSON DISEASE; RATS;

ANIMALIA; CAENORHABDITIS; CAENORHABDITIS ELEGANS;

EID: 0037942718     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:20:2:173     Document Type: Article

References (50)

1. Abbott N. J. (2002) Astrocyte-endothelial interactions and blood-brain barrier permeability. J. Anat. 200, 629-638.
2. Airaksinen M. S. and Saarma M. (2002) The gdnf family: signalling, biological functions and therapeutic value. Nat. Rev Neurosci. 3, 383-394.
3. Albrecht P. J., Dahl J. P., Stoltzfus O. K., Levenson R., and Levison S. W. (2002) Ciliary neurotrophic factor activates spinal cord astrocytes, stimulating their production and release of fibroblast growth factor-2, to increase motor neuron survival. Exp. Neurol. 173, 46-62.
4. Araque A., Carmignoto G., and Haydon P. G. (2001) Dynamic signaling between astrocytes and neurons. Annu. Rev. Physiol. 63, 795-813.
5. Bassan M., Zamostiano R., Davidson A., Pinhasov A., Giladi E., Perl O., et al. (1999) Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide. J. Neurochem. 72, 1283-1293.
6. Beattie E. C., Stellwagen D., Morishita W., Bresnahan J. C., Ha B. K., Von Zastrow M., et al. (2002) Control of Synaptic Strength by Glial TNFalpha. Science 295, 2282-2285.
7. Brenneman D. E. and Gozes I. (1996)A femtomolar-acting neuroprotective peptide. J. Clin. Invest. 97, 2299-2307.
8. Chao M. V. (1994) The p75 neurotrophin receptor. J. Neurobiol. 25, 1373-1385.
9. Davies A. M. and Wright E. M. (1995) Neurotrophic factors: Neurotrophin autocrine loops. Curr. Biol. 5, 723-726.
10. Dreher Z., Tout S., and Stone J. (1994) Interactions of living astrocytes in vitro: Evidence of the development of contact spacing. Glia 11, 57-63.
11. Durocher Y., Perret S., and Kamen A. (2002) High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acid Res. 30, No. 2e9.
12. Forger N. G. and Breedlove S. M. (1987) Motoneuronal death during human fetal development. J. Comp. Neurol. 264, 118-122.
13. Fraser D. D., Mudrick-Donnon L. A., and MacVicar B. A. (1994) Astrocytic GABA receptors. Gila 11, 83-93.
14. Hansson E. and Rönnbäck L. (1990) Astrocytes in neurotransmission. Cell. Mol. Biol. 36, 487-496.
15. Hashino E., Shero M., Junghans D., Rohrer H., Milbrandt J., and Johnson E. M. J. (2001) GDNF and neurturin are target-derived factors essential for cranial parasympathetic neuron development. Development 128, 3773-3782.
16. Haydon P. G. (2001) GLIA: listening and talking to the synapse. Nat Rev Neurosci 2, 185-193.
17. Heumann R. (1994) Neurotrophin signaling. Curr. Opin. Neurobiol. 4, 668-679.
18. Hidalgo A., Kinrade E. F., and Georgiou M. (2001) The Drosophila neuregulin vein maintains glial survival during axon guidance in the CNS. Dev. Cell 1, 679-690.
19. Hyman C., Hofer M., Barde Y.-A., Juhasz M., Yancopoulos G. D., Squinto S. P., and Lindsay R. M. (1991) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350, 230-232.
20. Jing S., Wen D., Yu Y., Holst P., Luo Y., Fang M., et al. (1996) GDNF-induced activation of the Ret protein tyrosine kinase is mediated by GDNFR-α, a novel receptor for GDNF. Cell 85, 1113-1124.
21. Kim W. T., Rioult M. G., and Cornell-Bell A. H. (1994) Glutamate-induced calcium signaling in astrocytes. Glia 11, 173-184.
22. Kinrade E. F., Brates T., Tear G., and Hidalgo A. (2001) Roundabout signalling, cell contact and trophic support confine longitudinal glia and axons in the Drosophila CNS. Development 128, 207-216.
23. Kohara K., Kitamura A., Morishima M. and Tsumoto T. (2001) Activity-Dependent Transfer of Brain-Derived Neurotrophic Factor to Postsynaptic Neurons. Science 291, 2419-2498.
24. Korsching S. (1993) The neurotrophic factor concept: A reexamination. J. Neurosci. 13, 2739-2748.
25. Kruger G. and Morrison S. (2002) Brain repair by endogenous progenitors. Cell 110, 399-402.
26. Levi-Montalcini R. (1987) The nerve growth factor 35 years later. Science 237, 1154-1162.
27. Levi-Montalcini R. and Hamburger V. (1951) Selective growth-stimulating effects of mouse sarcoma on sensory and sympathetic nervous system of the chick embryo. J. Exp. Zool. 116, 321-361N.
28. Li J., Kelly J. F., Chernushevich I., Harrison D. J., and Thibault P. (2000) Separation and identification of peptides from gel-isolated membrane proteins using a microfabricated device for combined capillary electrophoresis/nanoelectroscopy mass spectrometry. Anal. Chem. 72, 599-609.
29. Lin L.-F. H., Doherty D. H., Lile J. D., BekteshS. and Collins F. (1993) GDNF: A glial cell-line derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 1130-1132.
30. Lin L.-F. H., Zhang T. J., Collins F., and Armes L. G. (1994) Purification and initial characterization of rat B49 glial cell line-derived neurotrophic factor. J. Neurochem. 63, 758-768.
31. Massagué J. (1996) Crossing the boundaries. Nature 382, 29-30.
32. Nagler K., Mauch D. H., and Pfrieger F. W. (2001) Glia-derived signals induce synapse formation in neurones of the rat central nervous system. J. Physiol. (Lond.) 533, 665-679.
33. Nakatomi H., Kuriu T., Okabe S., Yamamoto S., Hatano O., Kawahara N., et al. (2002) Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell 110, 429-441.
34. Nedergaard M. (1994) Direct signaling from astrocytes to neurons in cultures of mammalian brain cells. Science 263, 1768-1771.
35. Nishi R. (1994) Target-derived molecules that influence the development of neurons in the avian ciliary ganglion. J. Neurobiol. 25, 612-619.
36. O'Malley E. K., Sieber B.-A., Morrison R. S., Black I. B., and Dreyfus C. F. (1994) Nigral Type I astrocytes release a soluble factor that increases dopaminergic neuron survival through mechanisms distinct from basic fibroblast growth factor. Brain Res. 647, 83-90.
37. Panchision D. M., Martin-DeLeon P. A., Takeshima T., Johnston J. M., Shimoda K., Tsoulfas P., et al. (1998) An immortalized, type-1 a strocyte of mesencephalic origin source of a dopaminergic neurotrophic factor. J. Mol. Neurosci. 11, 209-221.
38. Peaire A. E., Takeshima T., Johnston J. M., Wada-Isoe K., Nakashima K., and Commissiong J. W. (2003) Production of dopaminergic neurons for cell therapy in the treatment of Parkinson's disease. J. Neurosci. Meth. 124, 61-74.
39. Pinon L. G., Robinson M., and Davies A. M. (1995) High specificity of neurotrophins in the embryonic chicken trigeminal system. Eur. J. Neurosci. 7, 2397-2402.
40. Purves D. (1986) The trophic theory of neural connections. Trends Neurosci. 9, 486-489.
41. Salm A. K. and McCarthy K. D. (1992) The evidence for astrocytes as a target for central noradrenergic activity: Expression of adrenergic receptors. Brain Res. Bull. 29, 265-275.
42. Shimoda K., Sauve Y., Marini A., Schwartz J. P., and Commissiong J. W. (1992) A high percentage yield of tyrosine hydroxylase-positive cells from rat E14 mesencephalic cell culture. Brain Res. 586, 319-331.
43. Shridhar V., Richard S., Shridhar R., et al. (1996) A gene from human chromosomal band 3p21.1 encodes a highly conserved arginine-rich-protein and is mutated in renal cell carcinomas. Oncogene 12, 1931-1939.
44. Song H., Stevens C. F., and Gage F. H. (2002) Astroglia induce neurogenesis from adult stem cells. Nature 417, 39-44.
45. Takeshima T., Johnston J. M., and Commissiong J. W. (1994) Mesencephalic type 1 astrocytes rescue dopaminergic neurons from death induced by serum deprivation. J. Neurosci. 14, 4769-4779.
46. Takeshima T., Shimoda K., Johnston J. M., and Commissiong J. W. (1996) Standardized methods to bioassay neurotrophic factors for dopaminergic neurons. J. Neurosci. Meth. 67, 27-41.
47. Ullian E. M., Sapperstein S. K., Christopherson K. S., and Barres B. A. (2001) Control of synapse number by glia. Science 291, 657-660.
48. Van Wagoner N. J., Oh J. W., Repovic P., and Benveniste E. N. (1999) Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor. J. Neurosci. 19, 5236-5244.
49. Vogel K. S. and Davies A. M. (1991) The duration of neurotrophic factor independence in early sensory neurons is matched to the time course of target field innervation. Neuron 7, 819-830.
50. Wichterle H., Lieberam I., Porter J. A., and Jessell T. M. (2002) Directed differentiation of embryonic stem cells into motor neurons. Cell 110, 385-397.